AstraZeneca signs deal with NetScientific for COVID-19 test
- BySeeking Alpha-
Symbol | Exchange | Currency |
|---|
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Neutral | Neutral |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Buy | Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.64 | 0.00 | 0.00 | +0.05 | +8.47% | 1.19K | Lagos | |||
| 4.60 | 4.79 | 4.79 | -0.020 | -0.42% | 1.01M | Lagos | |||
| 8.90 | 8.90 | 8.90 | 0.00 | 0.00% | 1.65K | Lagos | |||
| 3.15 | 3.15 | 3.15 | +0.15 | +5.00% | 18.63K | Lagos | |||
| 0.48 | 0.00 | 0.00 | -0.01 | -2.04% | 1.60M | Lagos | |||
| 1.54 | 1.54 | 1.54 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.23 | 0.00 | 0.00 | 0.00 | 0.00% | 14.54M | Lagos | |||
| 4.50 | 4.50 | 4.50 | -0.200 | -4.26% | 32.41K | Lagos | |||
| 0.60 | 0.00 | 0.00 | 0.00 | 0.00% | 353.49K | Lagos | |||
| 0.78 | 0.00 | 0.00 | +0.03 | +4.00% | 100.00 | Lagos | |||
| 1.20 | 1.20 | 1.17 | +0.01 | +0.84% | 2.77M | Lagos | |||
| 50.00 | 50.00 | 50.00 | -2.95 | -5.57% | 86.15K | Lagos | |||
| 1.30 | 1.30 | 1.30 | +0.110 | +9.24% | 311.90K | Lagos | |||
| 20.30 | 20.30 | 20.30 | -0.50 | -2.40% | 80.22K | Lagos | |||
| 1.09 | 1.08 | 1.07 | -0.03 | -2.70% | 2.29M | Lagos |
NetScientific plc is a venture capital firm specializing in seed, early and mid stage investments. The firm focuses to invest in transformative biomedical and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets and in the United States. It typically invests up to $15 million, but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. NetScientific plc was founded in 2008 and is based in London, United Kingdom.